Kidney Cancer Clinical Trial

Clinical Trial Finder Kidney Cancer Trials

Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer

See Locations Near You

Summary

Axitinib dose titration (giving a higher dose of the drug above its standard starting dose) among certain patients may improve the response to treatment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

metastatic renal cell carcinoma (kidney cancer) with clear cell component
no prior systemic therapy (including no prior adjuvant or neoadjuvant)
Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1
Blood Pressure < or = 140/90mmHg

Exclusion Criteria:

brain/CNS metastasis
using more than 2 blood pressure medications

Study is for people with:

Kidney Cancer

Phase:

Phase 2

Estimated Enrollment:

213

Study ID:

NCT00835978

Recruitment Status:

Completed

Sponsor:

Pfizer

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 58 Locations for this study

See Locations Near You

East Bay Medical Oncology/Hematology Medical Associates Inc.
Antioch California, 94531, United States
Comprehensive Blood and Cancer Center
Bakersfield California, 93309, United States
Bay Area Cancer Research Group, LLC
Pleasant Hill California, 94523, United States
Diablo Valley Oncology and Hematology Medical Group Inc
Pleasant Hill California, 94523, United States
East Bay Medical Oncology/Hematology Medical Associates Inc
Pleasant Hill California, 94523, United States
East Bay Medical Oncology/Hematology Medical Associates Inc
San Leandro California, 94578, United States
H. Lee Moffitt Cancer Center and Research Institute
Tampa Florida, 33612, United States
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis Indiana, 46202, United States
Investigational Drug Services, IUHSCC
Indianapolis Indiana, 46202, United States
IU Health University Hospital
Indianapolis Indiana, 46202, United States
University of Maryland Greenebaum Cancer Center
Baltimore Maryland, 21201, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore Maryland, 21231, United States
Johns Hopkins Hospital
Baltimore Maryland, 21287, United States
Massachusetts General Hospital
Boston Massachusetts, 02114, United States
Beth Israel Deaconess Medical Center
Boston Massachusetts, 02215, United States
Cancer and Hematology Centers of Western Michigan
Grand Rapids Michigan, 49503, United States
Barnes-Jewish Hospital
Saint Louis Missouri, 63110, United States
Washington University
Saint Louis Missouri, 63110, United States
Nebraska Methodist Hospital
Omaha Nebraska, 68114, United States
University of Nebraska Medical Center
Omaha Nebraska, 68198, United States
Nevada Cancer Institute
Las Vegas Nevada, 89135, United States
The University Hospital
Cincinnati Ohio, 45219, United States
University of Cincinnati
Cincinnati Ohio, 45219, United States
Cleveland Clinic
Cleveland Ohio, 44195, United States
The Ohio State University, James Cancer Hospital
Columbus Ohio, 43210, United States
JamesCare in Kenny
Columbus Ohio, 43221, United States
West Chester Hospital Medical Building
West Chester Ohio, 45069, United States
Oregon Health and Science University
Portland Oregon, 97239, United States
Texas Oncology, Sammons Cancer Center
Dallas Texas, 75246, United States
The University of Texas MD Anderson Cancer Center
Houston Texas, 77030, United States
Virginia Mason Medical Center
Seattle Washington, 98101, United States
Masarykuv onkologicky ustav
Brno CZE, 656 5, Czechia
Fakultni nemocnice Olomouc Onkologicka klinika
Olomouc , 775 2, Czechia
Fakultni nemocnice Na Bulovce
Praha 8 , 180 8, Czechia
Krajska zdravotni, a.s. - Masarykova nemocnice V Usti nad Labem, o.z.
Usti nad Labem , 401 1, Czechia
Universitaetsklinikum Duesseldorf
Duesseldorf , 40225, Germany
Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II
Frankfurt , 60590, Germany
Medizinische Hochschule Hannover, Abt. Haematologie, Haemostaseologie & Onkologie
Hannover , 30625, Germany
Eberhardt-Karls-Universitaet Tuebingen, Klinik fuer Urologie
Tuebingen , 72076, Germany
Klinikum Weiden Klinik fuer Urologie, Andrologie und Kinderurologie
Weiden , 92637, Germany
Nagoya University Hospital
Nagoya Aichi, 466-8, Japan
Sapporo Medical University Hospital
Sapporo Hokkaido, 060-8, Japan
Hokkaido University Hospital
Sapporo Hokkaido, 060-8, Japan
Kobe University Hospital
Kobe Hyogo, 650-0, Japan
Kinki University Hospital
Osakasayama Osaka, 589-8, Japan
Hamamatsu University School of Medicine, University Hospital
Hamamatsu-City Shizuoka, 431-3, Japan
National Cancer Center
Chuo-ku Tokyo, 104-0, Japan
Japanese Foundation For Cancer Research Cancer Institute Hospital
Koto-ku Tokyo, 135-8, Japan
Keio University Hospital
Shinjuku-ku Tokyo, 160-8, Japan
Akita University Hospital
Akita , 010-8, Japan
Chiba Cancer Center
Chiba , 260-8, Japan
Kyushu University Hospital
Fukuoka , 812-8, Japan
Nagasaki University Hospital
Nagasaki , 852-8, Japan
Tokushima University Hospital
Tokushima , 770-8, Japan
Yamagata University Hospital
Yamagata , 990-9, Japan
Medical Radiology Research Center of the Minzdravsotsrazvitiya of Russia
Obninsk Kaluga Region, 24903, Russian Federation
State Healthcare Institution "Leningrad Regional Oncology Dispensary"
Poselok Kuzmolovskiy Vsevolozhskiy Region, Leningradskaya Oblast, 18866, Russian Federation
FSBSI "N.N. Blokhin Russian Cancer Research Center"
Moscow , 11547, Russian Federation
FSBI"Russian Scientific Center of Roengenoradiology" of the MH of RF
Moscow , 11799, Russian Federation
Saint-Petersburg's State Healthcare Institution 'City Clinical Oncology Dispensary'
Saint-Petersburg , 19702, Russian Federation
Saint-Petersburg's State Healthcare Institution 'City Clinical Oncology Dispensary'
Saint-Petersburg , 19825, Russian Federation
GBUZ "Samara Regional Clinical Oncology Dispensary"
Samara , 44303, Russian Federation
Hospital de La Princesa
Madrid , 28006, Spain
Hospital General Universitario Gregorio Marañon
Madrid , 28007, Spain
Hospital Universitario La Paz
Madrid , 28046, Spain
Load More

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Phase:

Phase 2

Estimated Enrollment:

213

Study ID:

NCT00835978

Recruitment Status:

Completed

Sponsor:


Pfizer

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider